IMPEDIMED LIMITED - Announcements

0.00%

4.5¢

Market Cap $91.34M

Technology Scientific & Technical Instruments

ImpediMed Limited is an Australia-based medical technology company. The Company uses... ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IPD	Quarterly Conference Call Details		29/01/19	168.59KB	Share
IPD	Ascension National Purchasing Agreement Received	PRICE SENSITIVE	16/01/19	255.84KB	Share
IPD	Change in substantial holding		07/01/19	565.03KB	Share
IPD	L-Dex Early Surveillance Reduces Incidence, Severity & Cost		10/12/18	90.45KB	Share
IPD	Bioimpedance & L-Dex Recommendation in Leading Journals		19/11/18	98.96KB	Share
IPD	Results of Meeting		17/10/18	60.29KB	Share
IPD	Annual General Meeting Presentation		17/10/18	8.62MB	Share
IPD	Chairman's Address		17/10/18	259.81KB	Share
IPD	Appendix 4C - Quarter ended 30 September 2018	PRICE SENSITIVE	16/10/18	400.5KB	Share
IPD	Health Plan Adopts SOZO for Monitoring CHF Patients		16/10/18	241.8KB	Share
IPD	ImpediMed Completes Asset Sale of XiTRON Technologies, Inc.	PRICE SENSITIVE	12/10/18	246.43KB	Share
IPD	First Patient Enrolled in 200 Patient Heart Failure Trial		10/10/18	245.44KB	Share
IPD	Notice of Annual General Meeting & Proxy Form		17/09/18	414.55KB	Share
IPD	SOZO Abstract Presentations at Key Cardiology Meetings		11/09/18	249.5KB	Share
IPD	S&P DJI Announces September 2018 Quarterly Rebalance	PRICE SENSITIVE	07/09/18	141.53KB	Share
IPD	Ceasing to be a substantial holder from MUFG		31/08/18	202.68KB	Share
IPD	Ceasing to be a substantial holder from MS		30/08/18	355.4KB	Share
IPD	Appendix 4G and Corporate Governance Statement		30/08/18	1.89MB	Share
IPD	Annual Report 30 June 2018		30/08/18	14.27MB	Share
IPD	Appendix 4E	PRICE SENSITIVE	30/08/18	234.55KB	Share
IPD	Becoming a substantial holder from MUFG		29/08/18	989.52KB	Share
IPD	Becoming a substantial holder from MS		28/08/18	1.38MB	Share
IPD	Response to ASX Aware Query	PRICE SENSITIVE	24/08/18	461.96KB	Share
IPD	L-Dex Suggested as a New Standard of Care	PRICE SENSITIVE	24/08/18	234.17KB	Share
IPD	PREVENT Trial Results Published - Outstanding Initial Data	PRICE SENSITIVE	23/08/18	230.29KB	Share
IPD	Ceasing to be a substantial holder from MUFG		15/08/18	290.39KB	Share
IPD	Ceasing to be a substantial holder from MS		14/08/18	443.99KB	Share
IPD	Change in substantial holding from MQG		13/08/18	677.97KB	Share
IPD	Becoming a substantial holder from MUFG		10/08/18	1.07MB	Share
IPD	Becoming a substantial holder from MS		09/08/18	1.5MB	Share
IPD	ImpediMed to present at Canaccord Growth Conference in USA		07/08/18	11.85MB	Share
IPD	Appendix 3B		31/07/18	149.4KB	Share
IPD	Ceasing to be a substantial holder from MUFG		30/07/18	187.02KB	Share
IPD	Ceasing to be a substantial holder from MS		27/07/18	333.2KB	Share
IPD	Becoming a substantial holder from MUFG		27/07/18	968.02KB	Share
IPD	Becoming a substantial holder from MS		26/07/18	1.35MB	Share
IPD	Investor Presentation		23/07/18	11.57MB	Share
IPD	Appendix 4C - Quarter ended 30 June 2018	PRICE SENSITIVE	23/07/18	412.62KB	Share
IPD	ImpediMed Quarterly Results and Investor Conference Call		20/07/18	105.11KB	Share
IPD	Becoming a substantial holder from MQG		03/07/18	520.66KB	Share
IPD	Ceasing to be a substantial holder from MQG		29/06/18	515.06KB	Share
IPD	Becoming a substantial holder from MQG		28/06/18	739.62KB	Share
IPD	SOZO Presentation at World Congress on Heart Disease		20/06/18	108.94KB	Share
IPD	Change of Director's Interest Notice		12/06/18	273.77KB	Share
IPD	Notification under section 708A(5)(e)		05/06/18	26.62KB	Share
IPD	Appendix 3B		05/06/18	109.37KB	Share
IPD	Change of Director's Interest Notice		30/05/18	62.54KB	Share
IPD	Assessment with L-Dex Features at ALA		23/05/18	133.77KB	Share
IPD	L-Dex Featured at American Society of Breast Surgeons		10/05/18	53.39KB	Share
IPD	Notification under section 708A(5)(e)		01/05/18	49.73KB	Share
IPD	Appendix 3B		01/05/18	155.05KB	Share
IPD	Appendix 4C - Quarter ended 31 March 2018	PRICE SENSITIVE	26/04/18	316.07KB	Share
IPD	ImpediMed Quarterly Results & Investor Conference Call		24/04/18	40.97KB	Share
IPD	Interim Results of PREVENT Trial	PRICE SENSITIVE	19/04/18	57.33KB	Share
IPD	US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment	PRICE SENSITIVE	17/04/18	70.88KB	Share
IPD	ImpediMed & Sharp HealthCare Sign Agreement for SOZO	PRICE SENSITIVE	07/03/18	53.75KB	Share
IPD	Appendix 4D and Interim Financial Report	PRICE SENSITIVE	22/02/18	4.9MB	Share
IPD	Change in substantial holding		14/02/18	95.5KB	Share
IPD	Appendix 4C - Quarter ended 31 December 2017	PRICE SENSITIVE	30/01/18	420.77KB	Share
IPD	Quarterly Results and Investor Conference Call Notification		29/01/18	49.84KB	Share
IPD	PREVENT Trial Enrolment Reaches 1,100 Patients		29/12/17	54.04KB	Share
IPD	Notification under section 708A(5)(e)		28/12/17	68.78KB	Share
IPD	Appendix 3B		28/12/17	141.1KB	Share
IPD	US FDA 510(k) Clearance Issued for CHF Monitoring with SOZO	PRICE SENSITIVE	27/12/17	63.14KB	Share
IPD	Notification under section 708A(5)(e)		18/12/17	39.96KB	Share
IPD	Appendix 3B		18/12/17	137.63KB	Share
IPD	Link Market Services - Change of Brisbane Address		18/12/17	169.43KB	Share
IPD	Notification under section 708A(5)(e)		12/12/17	39.85KB	Share
IPD	Appendix 3B		12/12/17	137.58KB	Share
IPD	Change of Director's Interest Notice		11/12/17	101.52KB	Share
IPD	Notification under section 708A(5)(e)		11/12/17	39.96KB	Share
IPD	Appendix 3B		11/12/17	138.32KB	Share
IPD	Notification under section 708A(5)(e)		06/12/17	39.85KB	Share
IPD	Appendix 3B		06/12/17	137.23KB	Share
IPD	L-Dex Abstracts Released - Breast Cancer Symposium		01/12/17	60.33KB	Share
IPD	Final Director's Interest Notice		16/11/17	69.15KB	Share
IPD	Initial Director's Interest Notice		16/11/17	54.74KB	Share
IPD	Change of Director's Interest Notice		16/11/17	65.37KB	Share
IPD	Appendix 3B		16/11/17	145.48KB	Share
IPD	Change in substantial holding		15/11/17	437.17KB	Share
IPD	Chairman's Address		15/11/17	58.69KB	Share
IPD	Annual General Meeting Presentation		09/11/17	9.57MB	Share
IPD	L-Dex Abstracts to be Presented at Breast Cancer Symposium	PRICE SENSITIVE	08/11/17	195.64KB	Share
IPD	2018 Reimbursement Amounts Published by CMS	PRICE SENSITIVE	06/11/17	41.24KB	Share
IPD	Multi-year Exclusive Distribution Agreement Signed	PRICE SENSITIVE	31/10/17	86.31KB	Share
IPD	Change in substantial holding		27/10/17	265.12KB	Share
IPD	Change in substantial holding		27/10/17	230.35KB	Share
IPD	Appendix 4C - Quarter ended 30 September 2017	PRICE SENSITIVE	25/10/17	504.98KB	Share
IPD	ImpediMed Quarterly Results & Investor Conference Call		24/10/17	87.86KB	Share
IPD	Shipments of SOZO with L-Dex Commence in the US	PRICE SENSITIVE	23/10/17	84.09KB	Share
IPD	Publication of Major Study in Leading Medical Journal	PRICE SENSITIVE	23/10/17	96.59KB	Share
IPD	Notice of Annual General Meeting & Proxy Form		16/10/17	397.83KB	Share
IPD	ImpediMed announces changes to Board of Directors		16/10/17	84.27KB	Share
IPD	Notification under section 708A(5)(e)		15/09/17	80.34KB	Share
IPD	Appendix 3B		15/09/17	203.91KB	Share
IPD	Change of Director's Interest Notice		30/08/17	101.78KB	Share
IPD	New Study Reports Superior Clinical Outcomes Utilising L-Dex	PRICE SENSITIVE	24/08/17	145.43KB	Share
IPD	Appendix 4G and Corporate Governance Statement		23/08/17	832.84KB	Share
IPD	2017 Annual Report		23/08/17	8.95MB	Share
IPD	Appendix 4E - year ended 30 June 2017	PRICE SENSITIVE	23/08/17	209.7KB	Share

IPD Quarterly Conference Call Details
29/01/19		168.59KB	Share
IPD Ascension National Purchasing Agreement Received
16/01/19	PRICE SENSITIVE	255.84KB	Share
IPD Change in substantial holding
07/01/19		565.03KB	Share
IPD L-Dex Early Surveillance Reduces Incidence, Severity & Cost
10/12/18		90.45KB	Share
IPD Bioimpedance & L-Dex Recommendation in Leading Journals
19/11/18		98.96KB	Share
IPD Results of Meeting
17/10/18		60.29KB	Share
IPD Annual General Meeting Presentation
17/10/18		8.62MB	Share
IPD Chairman's Address
17/10/18		259.81KB	Share
IPD Appendix 4C - Quarter ended 30 September 2018
16/10/18	PRICE SENSITIVE	400.5KB	Share
IPD Health Plan Adopts SOZO for Monitoring CHF Patients
16/10/18		241.8KB	Share
IPD ImpediMed Completes Asset Sale of XiTRON Technologies, Inc.
12/10/18	PRICE SENSITIVE	246.43KB	Share
IPD First Patient Enrolled in 200 Patient Heart Failure Trial
10/10/18		245.44KB	Share
IPD Notice of Annual General Meeting & Proxy Form
17/09/18		414.55KB	Share
IPD SOZO Abstract Presentations at Key Cardiology Meetings
11/09/18		249.5KB	Share
IPD S&P DJI Announces September 2018 Quarterly Rebalance
07/09/18	PRICE SENSITIVE	141.53KB	Share
IPD Ceasing to be a substantial holder from MUFG
31/08/18		202.68KB	Share
IPD Ceasing to be a substantial holder from MS
30/08/18		355.4KB	Share
IPD Appendix 4G and Corporate Governance Statement
30/08/18		1.89MB	Share
IPD Annual Report 30 June 2018
30/08/18		14.27MB	Share
IPD Appendix 4E
30/08/18	PRICE SENSITIVE	234.55KB	Share
IPD Becoming a substantial holder from MUFG
29/08/18		989.52KB	Share
IPD Becoming a substantial holder from MS
28/08/18		1.38MB	Share
IPD Response to ASX Aware Query
24/08/18	PRICE SENSITIVE	461.96KB	Share
IPD L-Dex Suggested as a New Standard of Care
24/08/18	PRICE SENSITIVE	234.17KB	Share
IPD PREVENT Trial Results Published - Outstanding Initial Data
23/08/18	PRICE SENSITIVE	230.29KB	Share
IPD Ceasing to be a substantial holder from MUFG
15/08/18		290.39KB	Share
IPD Ceasing to be a substantial holder from MS
14/08/18		443.99KB	Share
IPD Change in substantial holding from MQG
13/08/18		677.97KB	Share
IPD Becoming a substantial holder from MUFG
10/08/18		1.07MB	Share
IPD Becoming a substantial holder from MS
09/08/18		1.5MB	Share
IPD ImpediMed to present at Canaccord Growth Conference in USA
07/08/18		11.85MB	Share
IPD Appendix 3B
31/07/18		149.4KB	Share
IPD Ceasing to be a substantial holder from MUFG
30/07/18		187.02KB	Share
IPD Ceasing to be a substantial holder from MS
27/07/18		333.2KB	Share
IPD Becoming a substantial holder from MUFG
27/07/18		968.02KB	Share
IPD Becoming a substantial holder from MS
26/07/18		1.35MB	Share
IPD Investor Presentation
23/07/18		11.57MB	Share
IPD Appendix 4C - Quarter ended 30 June 2018
23/07/18	PRICE SENSITIVE	412.62KB	Share
IPD ImpediMed Quarterly Results and Investor Conference Call
20/07/18		105.11KB	Share
IPD Becoming a substantial holder from MQG
03/07/18		520.66KB	Share
IPD Ceasing to be a substantial holder from MQG
29/06/18		515.06KB	Share
IPD Becoming a substantial holder from MQG
28/06/18		739.62KB	Share
IPD SOZO Presentation at World Congress on Heart Disease
20/06/18		108.94KB	Share
IPD Change of Director's Interest Notice
12/06/18		273.77KB	Share
IPD Notification under section 708A(5)(e)
05/06/18		26.62KB	Share
IPD Appendix 3B
05/06/18		109.37KB	Share
IPD Change of Director's Interest Notice
30/05/18		62.54KB	Share
IPD Assessment with L-Dex Features at ALA
23/05/18		133.77KB	Share
IPD L-Dex Featured at American Society of Breast Surgeons
10/05/18		53.39KB	Share
IPD Notification under section 708A(5)(e)
01/05/18		49.73KB	Share
IPD Appendix 3B
01/05/18		155.05KB	Share
IPD Appendix 4C - Quarter ended 31 March 2018
26/04/18	PRICE SENSITIVE	316.07KB	Share
IPD ImpediMed Quarterly Results & Investor Conference Call
24/04/18		40.97KB	Share
IPD Interim Results of PREVENT Trial
19/04/18	PRICE SENSITIVE	57.33KB	Share
IPD US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment
17/04/18	PRICE SENSITIVE	70.88KB	Share
IPD ImpediMed & Sharp HealthCare Sign Agreement for SOZO
07/03/18	PRICE SENSITIVE	53.75KB	Share
IPD Appendix 4D and Interim Financial Report
22/02/18	PRICE SENSITIVE	4.9MB	Share
IPD Change in substantial holding
14/02/18		95.5KB	Share
IPD Appendix 4C - Quarter ended 31 December 2017
30/01/18	PRICE SENSITIVE	420.77KB	Share
IPD Quarterly Results and Investor Conference Call Notification
29/01/18		49.84KB	Share
IPD PREVENT Trial Enrolment Reaches 1,100 Patients
29/12/17		54.04KB	Share
IPD Notification under section 708A(5)(e)
28/12/17		68.78KB	Share
IPD Appendix 3B
28/12/17		141.1KB	Share
IPD US FDA 510(k) Clearance Issued for CHF Monitoring with SOZO
27/12/17	PRICE SENSITIVE	63.14KB	Share
IPD Notification under section 708A(5)(e)
18/12/17		39.96KB	Share
IPD Appendix 3B
18/12/17		137.63KB	Share
IPD Link Market Services - Change of Brisbane Address
18/12/17		169.43KB	Share
IPD Notification under section 708A(5)(e)
12/12/17		39.85KB	Share
IPD Appendix 3B
12/12/17		137.58KB	Share
IPD Change of Director's Interest Notice
11/12/17		101.52KB	Share
IPD Notification under section 708A(5)(e)
11/12/17		39.96KB	Share
IPD Appendix 3B
11/12/17		138.32KB	Share
IPD Notification under section 708A(5)(e)
06/12/17		39.85KB	Share
IPD Appendix 3B
06/12/17		137.23KB	Share
IPD L-Dex Abstracts Released - Breast Cancer Symposium
01/12/17		60.33KB	Share
IPD Final Director's Interest Notice
16/11/17		69.15KB	Share
IPD Initial Director's Interest Notice
16/11/17		54.74KB	Share
IPD Change of Director's Interest Notice
16/11/17		65.37KB	Share
IPD Appendix 3B
16/11/17		145.48KB	Share
IPD Change in substantial holding
15/11/17		437.17KB	Share
IPD Chairman's Address
15/11/17		58.69KB	Share
IPD Annual General Meeting Presentation
09/11/17		9.57MB	Share
IPD L-Dex Abstracts to be Presented at Breast Cancer Symposium
08/11/17	PRICE SENSITIVE	195.64KB	Share
IPD 2018 Reimbursement Amounts Published by CMS
06/11/17	PRICE SENSITIVE	41.24KB	Share
IPD Multi-year Exclusive Distribution Agreement Signed
31/10/17	PRICE SENSITIVE	86.31KB	Share
IPD Change in substantial holding
27/10/17		265.12KB	Share
IPD Change in substantial holding
27/10/17		230.35KB	Share
IPD Appendix 4C - Quarter ended 30 September 2017
25/10/17	PRICE SENSITIVE	504.98KB	Share
IPD ImpediMed Quarterly Results & Investor Conference Call
24/10/17		87.86KB	Share
IPD Shipments of SOZO with L-Dex Commence in the US
23/10/17	PRICE SENSITIVE	84.09KB	Share
IPD Publication of Major Study in Leading Medical Journal
23/10/17	PRICE SENSITIVE	96.59KB	Share
IPD Notice of Annual General Meeting & Proxy Form
16/10/17		397.83KB	Share
IPD ImpediMed announces changes to Board of Directors
16/10/17		84.27KB	Share
IPD Notification under section 708A(5)(e)
15/09/17		80.34KB	Share
IPD Appendix 3B
15/09/17		203.91KB	Share
IPD Change of Director's Interest Notice
30/08/17		101.78KB	Share
IPD New Study Reports Superior Clinical Outcomes Utilising L-Dex
24/08/17	PRICE SENSITIVE	145.43KB	Share
IPD Appendix 4G and Corporate Governance Statement
23/08/17		832.84KB	Share
IPD 2017 Annual Report
23/08/17		8.95MB	Share
IPD Appendix 4E - year ended 30 June 2017
23/08/17	PRICE SENSITIVE	209.7KB	Share

REFRESH

First 6 7 8 9 10

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.5¢		Change 0.000(0.00%)		Mkt cap ! $91.34M

Open	High	Low	Value	Volume
4.5¢	4.5¢	4.5¢	$9.215K	204.7K

Buyers (Bids)

No.	Vol.	Price($)
1	227204	4.4¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	112547	2

View Market Depth

No.	Vol.	Price($)
1	227204	0.044
2	323255	0.043
1	25000	0.042
6	380000	0.040
4	235000	0.039

Price($)	Vol.	No.
0.047	112547	2
0.048	548129	2
0.050	70000	2
0.051	70000	2
0.052	243123	2

Last trade - 15.08pm 08/08/2025 (20 minute delay)

IPD (ASX) Chart

IMPEDIMED LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available